A regenerative medicine company in Vancouver, British Columbia that focuses on treatments for nerve damage and neurodegenerative diseases announced it will begin Phase 1 studies in early 2020 on a new treatment for Alzheimer’s disease.
By usnewsr1-
Related Post
0
0
votes
Article Rating
Subscribe
Login
0 Comments
Oldest
Newest
Most Voted

